PL2128612T3 - Monitorowanie immunologiczne na podstawie IP-10 - Google Patents
Monitorowanie immunologiczne na podstawie IP-10Info
- Publication number
- PL2128612T3 PL2128612T3 PL09170735T PL09170735T PL2128612T3 PL 2128612 T3 PL2128612 T3 PL 2128612T3 PL 09170735 T PL09170735 T PL 09170735T PL 09170735 T PL09170735 T PL 09170735T PL 2128612 T3 PL2128612 T3 PL 2128612T3
- Authority
- PL
- Poland
- Prior art keywords
- cmi
- present
- invention further
- immunological monitoring
- relates
- Prior art date
Links
- 230000001900 immune effect Effects 0.000 title abstract 2
- 238000012544 monitoring process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000012472 biological sample Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000009257 reactivity Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
- G01N33/505—Cells of the immune system involving T-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56927—Chlamydia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/32—Mycobacterium
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/02—Hepadnaviridae, e.g. hepatitis B virus
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
- G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
- G01N2333/16—HIV-1, HIV-2
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/44—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from protozoa
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Jellies, Jams, And Syrups (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200601145 | 2006-09-05 | ||
| DKPA200700262 | 2007-02-20 | ||
| EP09170735A EP2128612B1 (en) | 2006-09-05 | 2007-09-05 | IP-10 based immunological monitoring |
| EP07801367A EP2059816A2 (en) | 2006-09-05 | 2007-09-05 | Ip-i0 based immunological monitoring |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2128612T3 true PL2128612T3 (pl) | 2011-09-30 |
Family
ID=38716188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09170735T PL2128612T3 (pl) | 2006-09-05 | 2007-09-05 | Monitorowanie immunologiczne na podstawie IP-10 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US8026076B2 (enExample) |
| EP (4) | EP2128612B1 (enExample) |
| JP (1) | JP5805368B2 (enExample) |
| KR (1) | KR101248491B1 (enExample) |
| CN (1) | CN101523217B (enExample) |
| AT (1) | ATE504000T1 (enExample) |
| AU (1) | AU2007294293B2 (enExample) |
| BR (1) | BRPI0714744B8 (enExample) |
| CA (1) | CA2662429C (enExample) |
| DE (1) | DE602007013620D1 (enExample) |
| DK (2) | DK2128612T3 (enExample) |
| EA (1) | EA020412B1 (enExample) |
| IN (1) | IN2015DN03125A (enExample) |
| PL (1) | PL2128612T3 (enExample) |
| PT (1) | PT2128612E (enExample) |
| WO (1) | WO2008028489A2 (enExample) |
| ZA (1) | ZA200902297B (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0722105D0 (en) | 2007-11-10 | 2007-12-19 | Sec Dep For Environment Food A | Antigens |
| MX2010014556A (es) * | 2008-06-25 | 2011-07-28 | Baylor Res Inst | Firma transcripcional de sangre por infeccion de mycobacterium tuberculosis. |
| CN102105786B (zh) * | 2008-07-25 | 2014-10-29 | 赛乐思迪斯有限公司 | 诊断方法 |
| CN102246040B (zh) * | 2008-12-15 | 2014-11-05 | 安特鲁姆生物技术（私人）有限公司 | 用于诊断结核病的方法和装置 |
| GB0906215D0 (en) | 2009-04-09 | 2009-05-20 | Lalvani Ajit | Diagnostic test |
| DK2365332T3 (da) * | 2010-03-10 | 2013-08-26 | Pasteur Institut | HMGB1- og anti-HMGB1-antistoffer i HIV-inficerede patienter, især med neurologiske lidelser |
| US20130078657A1 (en) * | 2010-05-04 | 2013-03-28 | Hvidovre Hospital | Hyperthermia augmented in-vitro immune recognition |
| WO2012076020A1 (en) * | 2010-12-09 | 2012-06-14 | Hvidovre Hospital | A method for generating, storing, transporting, eluting and detecting clinical relevant information in plasma using filter paper |
| WO2012139591A1 (en) | 2011-04-13 | 2012-10-18 | Hvidovre Hospital | Monitoring liver fibrosis in a hepatitis c infected patient |
| EP2702076A1 (en) * | 2011-04-29 | 2014-03-05 | Bristol-Myers Squibb Company | Ip-10 antibody dosage escalation regimens |
| CN103122033B (zh) * | 2011-11-21 | 2015-08-19 | 厦门大学 | 一种嵌合重组抗原及其用途 |
| WO2013087917A1 (en) * | 2011-12-15 | 2013-06-20 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and kits for diagnosing latent tuberculosis infection |
| ES2886979T3 (es) | 2012-02-09 | 2021-12-21 | Memed Diagnostics Ltd | Distintivos y determinantes para diagnosticar infecciones y métodos para usarlos |
| WO2013168876A1 (ko) | 2012-05-11 | 2013-11-14 | 가톨릭대학교 산학협력단 | 이식 후 면역 상태를 모니터링 하는 키트 및 이를 이용한 면역 상태의 모니터링 방법 |
| JP6102438B2 (ja) | 2012-05-30 | 2017-03-29 | 三菱化学株式会社 | 軸受部材、端部部材、感光体ドラムユニット、プロセスカートリッジ、及び軸受部材の製造方法 |
| JP6020237B2 (ja) | 2013-02-15 | 2016-11-02 | 三菱化学株式会社 | 軸受部材、端部部材、感光体ドラムユニット、及び軸受部材の製造方法 |
| WO2015038624A1 (en) | 2013-09-10 | 2015-03-19 | Immusant, Inc. | Dosage of a gluten peptide composition |
| KR101542510B1 (ko) | 2014-01-15 | 2015-08-18 | 대한민국 | 초기 hiv-1 감염자에서 급속한 aids 질환 진행을 예측하기 위한 ip-10의 용도 |
| RU2016137685A (ru) * | 2014-02-26 | 2018-03-29 | Стелленбос Юниверсити | Способ диагностики туберкулеза |
| KR101590324B1 (ko) * | 2014-04-24 | 2016-02-01 | 연세대학교 산학협력단 | 향상된 결핵 진단 방법 |
| WO2015164747A1 (en) * | 2014-04-24 | 2015-10-29 | Immusant, Inc. | Methods for diagnosing celiac disease using circulating cytokines/chemokines |
| EP3180621B1 (en) | 2014-08-14 | 2020-04-01 | Memed Diagnostics Ltd. | Computational analysis of biological data using manifold and a hyperplane |
| KR101748296B1 (ko) | 2014-09-04 | 2017-06-19 | 연세대학교 산학협력단 | 마이코박테리움 압세수스 복합체 감염 폐질환 진단용 바이오마커 조성물 |
| US10370718B2 (en) | 2014-09-29 | 2019-08-06 | Immusant, Inc. | Use of HLA genetic status to assess or select treatment of celiac disease |
| EP3221344A2 (en) | 2014-11-21 | 2017-09-27 | Immusant Inc. | Peptides for use in treatment and diagnosis of type 1 diabetes |
| CN111624345A (zh) | 2014-12-11 | 2020-09-04 | 米密德诊断学有限公司 | 用于诊断多种感染的标记组合及其使用方法 |
| CN104897893A (zh) * | 2015-06-10 | 2015-09-09 | 复旦大学附属华山医院 | 一种基于结核特异性il-31检测的诊断结核分枝杆菌感染的试剂盒 |
| IL287757B (en) | 2016-03-03 | 2022-07-01 | Memed Diagnostics Ltd | Analyzing rna for diagnosing infection type |
| CA3015046A1 (en) | 2016-03-03 | 2017-09-08 | Memed Diagnostics Ltd. | Rna determinants for distinguishing between bacterial and viral infections |
| CN109804245B (zh) * | 2016-07-10 | 2022-10-25 | 米密德诊断学有限公司 | 感染的早期诊断 |
| EP4141448A1 (en) | 2016-07-10 | 2023-03-01 | MeMed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| WO2018060999A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of risk assessment and disease classification |
| WO2018060998A1 (en) | 2016-09-29 | 2018-04-05 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| CN108548917B (zh) * | 2018-03-01 | 2021-07-06 | 广州市雷德生物科技有限公司 | 一种记忆性免疫细胞的检测体系及其应用 |
| WO2020127908A2 (en) | 2018-12-20 | 2020-06-25 | Lophius Biosciences Gmbh | Method of detecting infection with pathogens causing tuberculosis |
| WO2021255237A1 (en) | 2020-06-19 | 2021-12-23 | Mikrogen Gmbh | Method of detecting infection with pathogens causing tuberculosis |
| WO2022169842A1 (en) * | 2021-02-02 | 2022-08-11 | Revelation Biosciences, Inc. | Rapid detection kits and methods for diagnosing infections of the respiratory tract |
| WO2022240887A1 (en) * | 2021-05-10 | 2022-11-17 | Icahn School Of Medicine At Mount Sinai | Methods for detecting and staging cellular viral immune responses |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4777130A (en) * | 1984-12-05 | 1988-10-11 | Andra Biologicals | Isolation of mycobacterial a 60 antigen for diagnostic purposes |
| EP1200466A2 (en) * | 1999-07-13 | 2002-05-02 | Statens Serum Institut | Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosisesat-6 gene family |
| US7897357B2 (en) * | 2000-10-18 | 2011-03-01 | The United States Of America As Represented By The Secretary Of The Navy | Assay for detecting immune responses involving antigen specific cytokine and/or antigen specific cytokine secreting T-cells |
| US20040038201A1 (en) | 2002-01-22 | 2004-02-26 | Whitehead Institute For Biomedical Research | Diagnostic and therapeutic applications for biomarkers of infection |
| WO2003063759A2 (en) * | 2002-01-31 | 2003-08-07 | Peptor Ltd. | Hsp peptides and analogs for modulation of immune responses via antigen presenting cells |
| AU2002952548A0 (en) | 2002-11-08 | 2002-11-21 | Cellestis Limited | Diagnostic assay |
| WO2005012907A1 (en) * | 2003-08-01 | 2005-02-10 | Renovar, Inc. | Systems and methods for characterizing kidney diseases |
| US7575862B2 (en) * | 2003-12-09 | 2009-08-18 | Asiagen Corporation | Assay systems, kits and methods for detecting microorganisms |
| GB2427471B (en) | 2004-03-04 | 2009-07-22 | Laura Manuelidis | Pre-symptomatic markers for diseases associated with transmissable spongiform encephalopaties |
| US20060051358A1 (en) * | 2004-05-24 | 2006-03-09 | Baylor Research Institute | Immune response assessment method |
| US7332294B2 (en) * | 2004-08-17 | 2008-02-19 | University Health Network | CXCL10-based diagnosis and treatment of respiratory illnesses |
| CA2478138A1 (en) | 2004-08-17 | 2006-02-17 | University Health Network | Cxcl10-based diagnosis and treatment of respiratory illnesses |
| EP1885852B1 (en) * | 2005-05-05 | 2010-08-25 | The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services | Methods and compositions for detecting immune responses |
| EP1767937A1 (en) * | 2005-09-27 | 2007-03-28 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Method of diagnosis of tuberculosis related immune restoration syndrome (IRS) |
| EP1994409A2 (en) * | 2006-03-14 | 2008-11-26 | Oregon Health and Science University | Methods for producing an immune response to tuberculosis |
| CN1866023B (zh) * | 2006-05-25 | 2010-11-03 | 上海市肺科医院 | 一种同步检测多种结核杆菌特异性分泌抗原的方法 |
-
2007
- 2007-09-05 IN IN3125DEN2015 patent/IN2015DN03125A/en unknown
- 2007-09-05 DE DE602007013620T patent/DE602007013620D1/de active Active
- 2007-09-05 CN CN200780032976.5A patent/CN101523217B/zh active Active
- 2007-09-05 AU AU2007294293A patent/AU2007294293B2/en active Active
- 2007-09-05 DK DK09170735.6T patent/DK2128612T3/da active
- 2007-09-05 AT AT09170735T patent/ATE504000T1/de active
- 2007-09-05 PT PT09170735T patent/PT2128612E/pt unknown
- 2007-09-05 EP EP09170735A patent/EP2128612B1/en active Active
- 2007-09-05 EP EP07801367A patent/EP2059816A2/en active Pending
- 2007-09-05 PL PL09170735T patent/PL2128612T3/pl unknown
- 2007-09-05 EP EP10168333A patent/EP2228651A1/en not_active Withdrawn
- 2007-09-05 EP EP10180905.1A patent/EP2261658B1/en active Active
- 2007-09-05 US US12/438,515 patent/US8026076B2/en active Active
- 2007-09-05 JP JP2009527015A patent/JP5805368B2/ja active Active
- 2007-09-05 WO PCT/DK2007/000399 patent/WO2008028489A2/en not_active Ceased
- 2007-09-05 EA EA200970246A patent/EA020412B1/ru unknown
- 2007-09-05 DK DK10180905T patent/DK2261658T3/en active
- 2007-09-05 CA CA2662429A patent/CA2662429C/en active Active
- 2007-09-05 BR BRPI0714744A patent/BRPI0714744B8/pt active IP Right Grant
- 2007-09-05 KR KR1020097006853A patent/KR101248491B1/ko active Active
-
2009
- 2009-04-02 ZA ZA2009/02297A patent/ZA200902297B/en unknown
-
2011
- 2011-09-26 US US13/245,521 patent/US20120015386A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200902297B (en) | Ip-i0 based immunological monitoring | |
| AU2002952548A0 (en) | Diagnostic assay | |
| DE602006007703D1 (de) | Verbesserte immuntestverfahren | |
| EP1563300A4 (en) | DIAGNOSTIC PROCEDURE FOR SPRUE / ZELIAKIE | |
| WO2005054853A3 (en) | Method for diagnosing diseases based on levels of anti-glycan antibodies | |
| HUP0203691A2 (hu) | Nemhagyományos transzmisszibilis ágens biológiai mintabeli jelenlétének kimutatásán alapuló eljárás szubakut transzmisszibilis spongiform encephalopathia diagnózisára | |
| WO2012100070A3 (en) | Methods and apparatus for detection of gluten sensitivity, and its differentiation from celiac disease | |
| WO2008154570A3 (en) | Method for stimulating saliva production during oral sample collection procedure | |
| IL175692A0 (en) | Method for diagnosing diseases based on levels of anti-glycan antibodies | |
| GB0706558D0 (en) | Diagnostic assay | |
| WO2010108245A3 (pt) | Uso de antígenos de leishmania em método diagnóstico, vacina e terapia para leishmaniose | |
| WO2005106476A3 (en) | Method for diagnosing infectious diseases | |
| WO2003068958A1 (fr) | Procede d'analyse d'un acide nucleique specifiant un gene presentant une modification de son niveau d'expression liee a la schizophrenie | |
| ATE415629T1 (de) | In-vitro-diagnoseverfahren und kit für eine schwarzschimmel-infektion | |
| GB0616238D0 (en) | Diagnostic Test | |
| CY1112415T1 (el) | Η πρωτεϊνη serum amyloid p-component (sap, samp) ως προγνωστικος και διαγνωστικος δεικτης για τον προγεννητικο ελεγχο της τρισωμιας 21 (συνδρομο down) | |
| WO2004028467A3 (en) | Diagnosis of bovine viral diarrhea virus | |
| EP2637022A1 (en) | Method of inspecting periodontal disease causing bacteria using outer membrane vesicle and measuring appliance of the same | |
| MX2008012888A (es) | Estuche (kit) para diagnostico multiespectro de enfermedades infecciosas en el recien nacido. | |
| WO2011153590A8 (en) | Use of interferon epsilon in methods of diagnosis and treatment | |
| RU2009129208A (ru) | Способ диагностики дисбактериоза полости рта | |
| Young | MODERN FATIGUE TESTING FOR COMMERCIAL RUBBER APPLICATIONS | |
| WO2005124362A3 (de) | Verfahren und testkit zur diagnose einer ischämischen herzschädigung, insbesondere der latenten chronischen formen, durch serologischen nachweis der myosin lechtkette-1 | |
| RU2006110845A (ru) | Способ дифференциальной диагностики бактериального лимфаденита и вирусного лимфаденита | |
| WO2001053830A3 (en) | Diagnostic method involving haemoglobin, haematocrit or reg blood cell count |